annual CFI:
$60.78M+$6.75M(+12.49%)Summary
- As of today (September 15, 2025), BBIO annual cash flow from investing activities is $60.78 million, with the most recent change of +$6.75 million (+12.49%) on December 31, 2024.
- During the last 3 years, BBIO annual CFI has risen by +$261.61 million (+130.27%).
- BBIO annual CFI is now -86.59% below its all-time high of $453.15 million, reached on December 31, 2022.
Performance
BBIO Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$13.00M-$11.41M(-715.17%)Summary
- As of today (September 15, 2025), BBIO quarterly cash flow from investing activities is -$13.00 million, with the most recent change of -$11.41 million (-715.17%) on June 30, 2025.
- Over the past year, BBIO quarterly CFI has dropped by -$16.04 million (-527.84%).
- BBIO quarterly CFI is now -108.69% below its all-time high of $149.70 million, reached on June 30, 2022.
Performance
BBIO quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$20.39M-$16.04M(-44.03%)Summary
- As of today (September 15, 2025), BBIO TTM cash flow from investing activities is $20.39 million, with the most recent change of -$16.04 million (-44.03%) on June 30, 2025.
- Over the past year, BBIO TTM CFI has dropped by -$43.02 million (-67.84%).
- BBIO TTM CFI is now -95.54% below its all-time high of $456.98 million, reached on September 30, 2022.
Performance
BBIO TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
BBIO Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.5% | -527.8% | -67.8% |
| 3 y3 years | +130.3% | -108.7% | -94.5% |
| 5 y5 years | +128.0% | +89.9% | +106.7% |
BBIO Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -86.6% | +130.3% | -108.7% | at low | -95.5% | at low |
| 5 y | 5-year | -86.6% | +128.0% | -108.7% | +95.4% | -95.5% | +105.5% |
| alltime | all time | -86.6% | +128.0% | -108.7% | +95.4% | -95.5% | +105.5% |
BBIO Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$13.00M(+715.2%) | $20.39M(-44.0%) |
| Mar 2025 | - | -$1.59M(-50.7%) | $36.43M(-40.1%) |
| Dec 2024 | $60.78M(+12.5%) | -$3.24M(-108.5%) | $60.78M(-5.0%) |
| Sep 2024 | - | $38.23M(+1157.8%) | $63.95M(+0.9%) |
| Jun 2024 | - | $3.04M(-86.6%) | $63.41M(-1.7%) |
| Mar 2024 | - | $22.75M(<-9900.0%) | $64.49M(+19.3%) |
| Dec 2023 | $54.03M(-88.1%) | -$66.00K(-100.2%) | $54.03M(-25.0%) |
| Sep 2023 | - | $37.68M(+814.8%) | $72.06M(-60.2%) |
| Jun 2023 | - | $4.12M(-66.5%) | $181.24M(-44.5%) |
| Mar 2023 | - | $12.30M(-31.5%) | $326.82M(-27.9%) |
| Dec 2022 | $453.15M(-325.6%) | $17.96M(-87.8%) | $453.15M(-0.8%) |
| Sep 2022 | - | $146.86M(-1.9%) | $456.98M(+23.8%) |
| Jun 2022 | - | $149.70M(+8.0%) | $369.09M(+67.9%) |
| Mar 2022 | - | $138.62M(+535.9%) | $219.85M(-209.5%) |
| Dec 2021 | -$200.83M | $21.80M(-63.0%) | -$200.83M(+43.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $58.97M(>+9900.0%) | -$139.61M(-42.7%) |
| Jun 2021 | - | $458.00K(-100.2%) | -$243.63M(-34.7%) |
| Mar 2021 | - | -$282.05M(-439.7%) | -$373.07M(+604.0%) |
| Dec 2020 | -$52.99M(-75.6%) | $83.02M(-284.3%) | -$52.99M(-65.3%) |
| Sep 2020 | - | -$45.05M(-65.1%) | -$152.91M(-49.9%) |
| Jun 2020 | - | -$128.98M(-439.2%) | -$305.20M(+72.6%) |
| Mar 2020 | - | $38.02M(-325.0%) | -$176.80M(-18.6%) |
| Dec 2019 | -$217.25M(+932.8%) | -$16.90M(-91.4%) | -$217.25M(+6.5%) |
| Sep 2019 | - | -$197.34M(>+9900.0%) | -$203.95M(+2727.2%) |
| Jun 2019 | - | -$583.00K(-76.0%) | -$7.21M(-12.9%) |
| Mar 2019 | - | -$2.43M(-32.6%) | -$8.29M(-60.6%) |
| Dec 2018 | -$21.04M(+4433.6%) | -$3.60M(+494.9%) | -$21.04M(+20.6%) |
| Sep 2018 | - | -$605.00K(-63.4%) | -$17.44M(+3.6%) |
| Jun 2018 | - | -$1.66M(-89.1%) | -$16.83M(+10.9%) |
| Mar 2018 | - | -$15.18M | -$15.18M |
| Dec 2017 | -$464.00K | - | - |
FAQ
- What is BridgeBio Pharma, Inc. annual cash flow from investing activities?
- What is the all time high annual CFI for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. annual CFI year-on-year change?
- What is BridgeBio Pharma, Inc. quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. quarterly CFI year-on-year change?
- What is BridgeBio Pharma, Inc. TTM cash flow from investing activities?
- What is the all time high TTM CFI for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. TTM CFI year-on-year change?
What is BridgeBio Pharma, Inc. annual cash flow from investing activities?
The current annual CFI of BBIO is $60.78M
What is the all time high annual CFI for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high annual cash flow from investing activities is $453.15M
What is BridgeBio Pharma, Inc. annual CFI year-on-year change?
Over the past year, BBIO annual cash flow from investing activities has changed by +$6.75M (+12.49%)
What is BridgeBio Pharma, Inc. quarterly cash flow from investing activities?
The current quarterly CFI of BBIO is -$13.00M
What is the all time high quarterly CFI for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high quarterly cash flow from investing activities is $149.70M
What is BridgeBio Pharma, Inc. quarterly CFI year-on-year change?
Over the past year, BBIO quarterly cash flow from investing activities has changed by -$16.04M (-527.84%)
What is BridgeBio Pharma, Inc. TTM cash flow from investing activities?
The current TTM CFI of BBIO is $20.39M
What is the all time high TTM CFI for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high TTM cash flow from investing activities is $456.98M
What is BridgeBio Pharma, Inc. TTM CFI year-on-year change?
Over the past year, BBIO TTM cash flow from investing activities has changed by -$43.02M (-67.84%)